Literature DB >> 15076637

The risk of celiac disease in 107 families with at least two affected siblings.

Audur H Gudjónsdóttir1, Staffan Nilsson, Johan Ek, Bengt Kristiansson, Henry Ascher.   

Abstract

OBJECTIVES: Screening for celiac disease (CD) in the apparently healthy members of 107 nuclear families with two affected siblings (sib pair) and estimating the risk of CD in siblings and parents.
METHODS: One hundred seven families from Sweden and southern Norway with at least two affected children were investigated. Frozen sera from 187 of the 192 healthy parents and from 94 of 95 siblings without diagnosed CD were examined for total immunoglobulin A (IgA) and anti-endomysial antibodies (EMA). Individuals with positive antibody titers underwent small intestinal biopsy.
RESULTS: Positive test for EMA was found in 6 of 94 (6.3%) siblings without previously diagnosed CD and in 8 of 189 (4.2%) parents. CD was confirmed by small intestinal biopsy in all siblings and seven parents. The estimated risk for CD in multiply affected families was 26.3% for siblings and 12.9% for parents. An unexpected male preponderance was found among the new CD cases (10 males, 3 females).
CONCLUSION: The risk of CD in the members of nuclear families with two affected children is approximately three times higher than that when only one child is affected. The high male preponderance of new cases is unexpected and could not be explained fully by more silent disease in males as compared with females. Considering the high level of knowledge about CD in these families, the number of undiagnosed cases is surprisingly high. The authors suggest that serologic screening should be offered to all first-degree relatives of patients with CD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076637     DOI: 10.1097/00005176-200403000-00020

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Predictors of family risk for celiac disease: a population-based study.

Authors:  Alberto Rubio-Tapia; Carol T Van Dyke; Brian D Lahr; Alan R Zinsmeister; Mounif El-Youssef; S Breanndan Moore; Martha Bowman; Lawrence J Burgart; L Joseph Melton; Joseph A Murray
Journal:  Clin Gastroenterol Hepatol       Date:  2008-06-30       Impact factor: 11.382

Review 2.  Risk factors in familial forms of celiac disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

Review 3.  Risk of Celiac Disease in the First- and Second-Degree Relatives of Patients With Celiac Disease: A Systematic Review and Meta-Analysis.

Authors:  Prashant Singh; Shubhangi Arora; Suman Lal; Tor A Strand; Govind K Makharia
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

4.  Practical considerations for the identification and follow-up of children with celiac disease.

Authors:  Martha H Dirks
Journal:  Paediatr Child Health       Date:  2004-12       Impact factor: 2.253

5.  Celiac disease in adult patients: specific autoantibodies in the diagnosis, monitoring, and screening.

Authors:  Evagelia Trigoni; Alexandra Tsirogianni; Elena Pipi; Gerassimos Mantzaris; Chryssa Papasteriades
Journal:  Autoimmune Dis       Date:  2014-04-03

6.  A possible mechanism behind autoimmune disorders discovered by genome-wide linkage and association analysis in celiac disease.

Authors:  Malin Östensson; Caroline Montén; Jonas Bacelis; Audur H Gudjonsdottir; Svetlana Adamovic; Johan Ek; Henry Ascher; Elisabet Pollak; Henrik Arnell; Lars Browaldh; Daniel Agardh; Jan Wahlström; Staffan Nilsson; Åsa Torinsson-Naluai
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

7.  Replication of GWAS Coding SNPs Implicates MMEL1 as a Potential Susceptibility Locus among Saudi Arabian Celiac Disease Patients.

Authors:  Omar I Saadah; Noor Ahmad Shaik; Babajan Banaganapalli; Mohammed A Salama; Sameer E Al-Harthi; Jun Wang; Harbi A Shawoosh; Sharifa A Alghamdi; Yagoub Y Bin-Taleb; Bakr H Alhussaini; Ramu Elango; Jumana Y Al-Aama
Journal:  Dis Markers       Date:  2015-12-30       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.